Use of abatacept in steroid refractory, immune checkpoint-induced myocarditis.

Kalapurackal Mathai, Vinod; Black, Allison; Lovibond, Sam; Binny, Simon; Lipton, Jonathan; Moldovan, Cristina

Kalapurackal Mathai, Vinod; Black, Allison; Lovibond, Sam; Binny, Simon; Lipton, Jonathan; Moldovan, Cristina.

Afiliação

Kalapurackal Mathai V; Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Black A; Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Lovibond S; Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Binny S; Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Lipton J; Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Moldovan C; Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia.

Intern Med J ; 51(11): 1971-1972, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34796633

Assuntos

Miocardite; Abatacepte; Humanos; Miocardite/induzido quimicamente; Miocardite/tratamento farmacológico; Nivolumabe; Esteroides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Miocardite Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google